Home > Financial Ratios > CONCORD DRUGS

CONCORD DRUGS
Price to Cash Earnings (PCE)

    Back to All Ratios
CONCORD DRUGS is part of below Screeners ↓
Best Quarterly Growth Small Cap Stocks
COMMUNITY POLL
for CONCORD DRUGS
Please provide your vote to see the results

CONCORD DRUGS Last 5 Year Price to Cash Earnings (PCE) History

[Consolidated]

Mar2025Mar2024Mar2023Mar2022
   PCE(x) 17.5917.349.797.55

What is the latest Price to Cash Earnings (PCE) ratio of CONCORD DRUGS ?

The latest Price to Cash Earnings (PCE) ratio of CONCORD DRUGS is 17.59 based on Mar2025 Consolidated results.
Year Price to Cash Earnings (PCE)
Mar202517.59
Mar202417.34
Mar20239.79
Mar20227.55

How is Price to Cash Earnings (PCE) of CONCORD DRUGS Trending?

Years Price to Cash Earnings (PCE) % Change
Mar2025 17.59
1.44
Mar2024 17.34
77.12
Mar2023 9.79
29.67
Mar2022 7.55 -

Other Financial Ratios of CONCORD DRUGS


Compare Price to Cash Earnings (PCE) ratio of peers of CONCORD DRUGS

Peers & Returns Market Capitalization 1 Week 1 Month 1 Year
CONCORD DRUGS ₹97.7 Cr 8.9% -2.8% 33.7% Stock Analytics
SUN PHARMACEUTICAL INDUSTRIES ₹477,312.0 Cr 0.8% 6.3% 18.2% Stock Analytics
DIVIS LABORATORIES ₹213,879.0 Cr 8.6% 20.7% 18.5% Stock Analytics
TORRENT PHARMACEUTICALS ₹194,094.0 Cr 1.7% 9.4% 38.5% Stock Analytics
CIPLA ₹118,992.0 Cr 4.5% 1.2% -1.4% Stock Analytics
DR REDDYS LABORATORIES ₹95,787.4 Cr -0.3% -14.8% -9.5% Stock Analytics


CONCORD DRUGS Share Price vs Sensex


Share Price Returns(%) 1 Week 1 Month 1 Year
CONCORD DRUGS

8.9%

-2.8%

33.7%

SENSEX

2.7%

1.5%

-5.6%


You may also like the below Video Courses